- Conditions
- B-Cell Non-Hodgkins Lymphoma, Cytokine Release Syndrome, Disease Attributes, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States
Clinical trial condition
Cytokine Release Syndrome
Explore clinical trials studying Cytokine Release Syndrome. Study availability and eligibility vary by location and protocol.
89 public trials
16 recruiting studies
Cytokine Release Syndrome trial results
NCT07657312
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +20 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
NCT06447376
- Conditions
- Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +24 more
- Locations
-
- Hospital Universitario Príncipe de Asturias Alcalá de Henares, Madrid, Spain
- Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain
- Hospital Universitario Reina Sofía Córdoba, Spain
NCT06377059
- Conditions
- CRS - Cytokine Release Syndrome, Cytokine Release Syndrome, Hematologic Cancer, +10 more
- Locations
-
- Rigshospitalet Copenhagen O, Denmark
NCT05972135
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +18 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Medical Oncology Hematology Consultants Newark, Delaware, United States
NCT05905328
- Conditions
- Cytokine Release Syndrome, Inflammation, Pathologic Processes, +3 more
- Locations
-
- University of California, Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Duke Cancer Institute Durham, North Carolina, United States
Recruiting
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
NCT06339177
- Conditions
- Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +26 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT05306080
- Conditions
- CRS - Cytokine Release Syndrome, Cytokine Release Syndrome, HLH, +5 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States